| # | Drug | Count |
|---|---|---|
| 0 | OMEPRAZOLE MAGNESIUM | 59 |
| 1 | LANSOPRAZOLE | 54 |
| 2 | OMEPRAZOLE | 44 |
| 3 | ETANERCEPT | 39 |
| 4 | ESOMEPRAZOLE MAGNESIUM | 32 |
| 5 | PANTOPRAZOLE | 32 |
| 6 | ADALIMUMAB | 28 |
| 7 | PREGABALIN | 25 |
| 8 | METHOTREXATE SODIUM | 24 |
| 9 | PREDNISONE | 23 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE | 3 | 0.0048 |
| 1 | RALTEGRAVIR | 11 | 0.0021 |
| 2 | ATAZANAVIR | 20 | 0.0014 |
| 3 | ELVITEGRAVIR, COBICISTAT, EMTRICITABINE, AND TENOFOVIR DISOPROXIL FUMARATE | 12 | 0.0013 |
| 4 | LEVOKETOCONAZOLE | 1 | 0.0013 |
| 5 | RITONAVIR 100 MG | 16 | 0.0011 |
| 6 | METHYLDOPA | 5 | 0.0010 |
| 7 | TELMISARTAN AND HYDROCHLOROTHIAZIDE | 2 | 0.0008 |
| 8 | METHENAMINE HIPPURATE | 1 | 0.0008 |
| 9 | GINKGO BILOBA | 1 | 0.0007 |
| # | Drug class | Count |
|---|---|---|
| 0 | Proton Pump Inhibitor [EPC] | 74 |
| 1 | Corticosteroid [EPC] | 63 |
| 2 | Tumor Necrosis Factor Blocker [EPC] | 46 |
| 3 | Nonsteroidal Anti-inflammatory Drug [EPC] | 35 |
| 4 | Angiotensin 2 Receptor Blocker [EPC] | 31 |
| 5 | Benzodiazepine [EPC] | 26 |
| 6 | Insulin Analog [EPC] | 25 |
| 7 | Kinase Inhibitor [EPC] | 25 |
| 8 | Atypical Antipsychotic [EPC] | 21 |
| 9 | Cytochrome P450 3A Inhibitor [EPC] | 21 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 2 | 0.0029 |
| 1 | Cortisol Synthesis Inhibitor [EPC] | 1 | 0.0013 |
| 2 | Provitamin D2 Compound [EPC] | 15 | 0.0005 |
| 3 | Guanylate Cyclase-C Agonist [EPC] | 1 | 0.0005 |
| 4 | Protease Inhibitor [EPC] | 21 | 0.0005 |
| 5 | Actinomycin [EPC] | 1 | 0.0005 |
| 6 | Neuraminidase Inhibitor [EPC] | 1 | 0.0004 |
| 7 | Cytochrome P450 3A Inhibitor [EPC] | 21 | 0.0003 |
| 8 | Nitrofuran Antibacterial [EPC] | 6 | 0.0003 |
| 9 | Uric Acid-specific Enzyme [EPC] | 1 | 0.0003 |